GlassScriptPhysician profile
Nicole Sutowski
NPI 1710600267
$1,236.24
in general payments reported to CMS, 2019-2025
22 companies · $676 in 2025
The $676 reported for 2025 was more than what 80% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $72.58 · 2024: $487 · 2025: $676.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,236.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,236.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $148.08 | 2024-2025 | Azstarys |
| Merck Sharp & Dohme LLC | $119.42 | 2023-2025 | Gardasil 9, Vaxneuvance, M-M-R II |
| Ironshore Pharmaceuticals INC. | $116.90 | 2024 | |
| Tolmar, INC. | $108.00 | 2024-2025 | Fensolvi |
| Alk-Abello, INC | $107.80 | 2025 | Neffy, Ragwitek, Odactra |
| Collegium Pharmaceutical, INC. | $93.36 | 2025 | Jornay Pm |
| Alexion Pharmaceuticals, INC. | $92.52 | 2024 | Strensiq |
| Kaleo, INC. | $52.92 | 2023 | Auvi-Q |
| Sanofi-Aventis U.S. LLC | $49.84 | 2025 | |
| Kyowa Kirin, INC. | $46.11 | 2025 | |
| Insulet Corporation | $43.55 | 2024 | Omnipod |
| Xeris Pharmaceuticals, INC. | $41.11 | 2024-2025 | Gvoke Hypopen |
| Azurity Pharmaceuticals, INC. | $41.01 | 2024 | Triptodur |
| Abbvie INC. | $31.82 | 2024-2025 | |
| Ultragenyx Pharmaceutical INC. | $23.32 | 2024 | Crysvita |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biomarin Pharmaceutical INC. | $22.25 | 2025 | Voxzogo 1.2mg |
| Tris Pharma INC | $21.30 | 2025 | Dyanavel Xr |
| Beta Bionics, INC. | $17.37 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Amphastar Pharmaceuticals, INC. | $16.53 | 2024 | |
| Tandem Diabetes Care, INC. | $15.54 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Cepheid | $13.86 | 2025 | Genexpert |
| Sequel Med Tech, LLC | $13.63 | 2025 | Twiist |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Sutowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.